Literature DB >> 10815138

The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians.

H A Crystal1, D Dickson, P Davies, D Masur, E Grober, R B Lipton.   

Abstract

CONTEXT: With the recent change in pathological criteria for Alzheimer disease (AD), a group of patients has emerged who do not meet pathological criteria for any well-characterized degenerative dementias. Whether these unclassified patients have vascular dementia or some other form of dementia is not known.
OBJECTIVE: To determine the clinical characteristics, pathological substrate, and relative frequency of dementia not caused by well-characterized degenerative dementias. DESIGN/
SETTING: Clinicopathological study of a prospectively observed sample of elderly nondemented and demented subjects recruited from our urban community.
METHODS: In our series of 128 subjects with prospective neuropsychological evaluations as well as neuropathology, we identified 35 clinically nondemented subjects and 20 demented patients who did not meet pathological criteria for well-characterized degenerative dementias such as AD or dementia with Lewy bodies. The 20 demented patients were grouped together under the term dementia of unknown etiology (DUE). We compared clinical, genetic, neuropsychological, pathological, and neurochemical characteristics of the nondemented group, patients with DUE, and 28 patients with AD and no other pathological abnormality.
RESULTS: Mean age at death for patients with DUE was 89.1 +/- 5.8 years compared with 79.9 +/- 11.4 years for AD (P<.001). Patients with AD and DUE did not differ in sex, risk factors, apolipoprotein E genotype, neuropsychological features, or neurological features. Hippocampal sclerosis (in 11 patients with dementia and no controls) and leukoencephalopathy (in 7 patients with dementia and 1 control) were associated with cognitive impairment; other vascular markers were not. Dementia of unknown etiology accounted for 5% of all cases of dementia among patients dying in their 70s, 21% for patients dying in their 80s, and 48% for patients dying in their 90s.
CONCLUSIONS: A significant percentage of demented patients older than 80 years do not meet pathological criteria for AD or dementia with Lewy bodies. Hippocampal sclerosis and leukoencephalopathy are common in these patients but rare in clinically nondemented subjects.

Entities:  

Mesh:

Year:  2000        PMID: 10815138     DOI: 10.1001/archneur.57.5.713

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  53 in total

1.  The relationship between attention and gait in aging: facts and fallacies.

Authors:  Roee Holtzer; Cuiling Wang; Joe Verghese
Journal:  Motor Control       Date:  2012-01       Impact factor: 1.422

Review 2.  Diagnosing dementia in the oldest-old.

Authors:  Carrie Brumback-Peltz; Archana B Balasubramanian; María M Corrada; Claudia H Kawas
Journal:  Maturitas       Date:  2011-08-09       Impact factor: 4.342

3.  Quantitative gait dysfunction and risk of cognitive decline and dementia.

Authors:  Joe Verghese; Cuiling Wang; Richard B Lipton; Roee Holtzer; Xiaonan Xue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-19       Impact factor: 10.154

4.  Leisure activities and the risk of amnestic mild cognitive impairment in the elderly.

Authors:  J Verghese; A LeValley; C Derby; G Kuslansky; M Katz; C Hall; H Buschke; R B Lipton
Journal:  Neurology       Date:  2006-02-08       Impact factor: 9.910

5.  Leisure activities and risk of vascular cognitive impairment in older adults.

Authors:  Joe Verghese; Mindy J Katz; Amy Sanders; Richard B Lipton
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-03-23       Impact factor: 2.680

Review 6.  Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.

Authors:  Peter T Nelson; Elizabeth Head; Frederick A Schmitt; Paulina R Davis; Janna H Neltner; Gregory A Jicha; Erin L Abner; Charles D Smith; Linda J Van Eldik; Richard J Kryscio; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-04-24       Impact factor: 17.088

Review 7.  Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging.

Authors:  Lisa Mosconi; Valentina Berti; Lidia Glodzik; Alberto Pupi; Susan De Santi; Mony J de Leon
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 8.  Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.

Authors:  Lisa Mosconi; Alberto Pupi; Mony J De Leon
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

9.  Contribution of vascular pathology to the clinical expression of dementia.

Authors:  Dorothea Strozyk; Dennis W Dickson; Richard B Lipton; Mindy Katz; Carol A Derby; Sunhee Lee; Cuiling Wang; Joe Verghese
Journal:  Neurobiol Aging       Date:  2008-11-08       Impact factor: 4.673

10.  Con: Can neuropathology really confirm the exact diagnosis?

Authors:  Kurt A Jellinger
Journal:  Alzheimers Res Ther       Date:  2010-05-07       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.